Skip to main content

D. E. Shaw & Co., Inc.

Position in IMVT — Immunovant, Inc.

CIK 1009207 New York, NY

Position in IMVT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$47,802,398
+$46,888,395 QoQ
Shares Held
1,240,654
+2088.1% QoQ
Ownership
0.601%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#23
of 226 holders
Holding Since
Mar 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,139,216,221 across 216 Biotechnology names. IMVT ranks #27 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IMVT

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $47,802,398 1,240,654
2025-09-30 $914,003 56,700
2025-06-30 $957,088 59,818
2025-03-31 $863,626 50,534
2024-12-31 $1,676,160 67,669
2024-09-30 $1,780,021 62,435
2024-06-30 $1,095,045 41,479
2024-03-31 $1,806,580 55,914
2023-12-31 $2,357,847 55,966
2023-09-30 $5,473,031 142,564
2023-06-30 $14,478,112 763,211
2023-03-31 $6,893,466 444,453
2022-12-31 $5,297,842 298,470
2021-12-31 $173,560 20,371
2021-03-31 $402,908 25,119